Karol Horvath

Title: The Innovations of Karol Horvath

Introduction

Karol Horvath is a notable inventor based in Karlskoga, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable suspensions. His work focuses on creating stable and effective formulations that can be administered through fine needles.

Latest Patents

Karol Horvath holds a patent for an "Injectable suspension comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, and a method for the manufacturing thereof." This invention relates to aseptic suspensions that are physically stable and injectable through a 25G needle or thinner. The formulation includes crystalline, non-micronized 3-beta-hydroxy-5-alpha-pregnan-20-one particles, a mixture of acylglycerols, and cholesterol. The patent also outlines processes for preparing these crystalline particles suitable for such suspensions, as well as methods for manufacturing the suspensions themselves.

Career Highlights

Karol is associated with Asarina Pharma AB, where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing the development of injectable medications that enhance patient care and treatment options.

Collaborations

He collaborates with notable colleagues such as Magnus Brisander and Björn Norrlind, contributing to a dynamic research environment that fosters innovation and development in the pharmaceutical sector.

Conclusion

Karol Horvath's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his commitment to advancing medical science. His work continues to impact the development of effective injectable treatments.